| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | C08CA06 |
| UNII | 57WA9QZ5WH |
| EPA CompTox | DTXSID5023370 |
| InChI Key | UIAGMCDKSXEBJQ-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26N2O7 |
| Molecular Weight | 418.45 |
| AlogP | 2.97 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 117.0 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 30.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Mineralocorticoid receptor antagonist | ANTAGONIST | PubMed |
|
Protein: Voltage-gated L-type calcium channel Description: Voltage-dependent L-type calcium channel subunit alpha-1F Organism : Homo sapiens O60840 ENSG00000102001 |
||||
|
Protein: Mineralocorticoid receptor Description: Mineralocorticoid receptor Organism : Homo sapiens P08235 ENSG00000151623 |
||||
|
Protein: Voltage-gated L-type calcium channel Description: Voltage-dependent L-type calcium channel subunit alpha-1D Organism : Homo sapiens Q01668 ENSG00000157388 |
||||
|
Protein: Voltage-gated L-type calcium channel Description: Voltage-dependent L-type calcium channel subunit alpha-1S Organism : Homo sapiens Q13698 ENSG00000081248 |
||||
|
Protein: Voltage-gated L-type calcium channel Description: Voltage-dependent L-type calcium channel subunit alpha-1C Organism : Homo sapiens Q13936 ENSG00000151067 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 7575 |
| ChEMBL | CHEMBL1428 |
| DrugBank | DB00393 |
| DrugCentral | 1937 |
| FDA SRS | 57WA9QZ5WH |
| Human Metabolome Database | HMDB0014537 |
| Guide to Pharmacology | 2523 |
| KEGG | C07267 |
| PharmGKB | PA450633 |
| PubChem | 4497 |
| SureChEMBL | SCHEMBL34041 |
| ZINC | ZINC19632718 |